88
Participants
Start Date
March 5, 2021
Primary Completion Date
March 15, 2021
Study Completion Date
March 23, 2021
coadministration of JP-1366 and aceclofenac
An open-label, multiple-dosing, fixed sequence, 3-period design
coadministration of JP-1366 and meloxicam
An open-label, multiple-dosing, fixed sequence, 3-period design
coadministration of JP-1366 and naproxen
An open-label, multiple-dosing, fixed sequence, 3-period design
single-dosing of JP-1366 in Korean and Caucasian
An open-label, single-dosing, parallel design
Cha University Bundang Medical Center, Gyeonggi-do
Lead Sponsor
Onconic Therapeutics Inc.
INDUSTRY